Document is current
Any future updates will be listed below
-
Authors
Galván, Gloria Cecilia https://orcid.org/0000-0001-5892-3340
Daniels, James P. https://orcid.org/0000-0002-2401-2474
Friedrich, Nadine A. https://orcid.org/0000-0002-6713-0614
Das, Sanjay
Freedland, Stephen J. https://orcid.org/0000-0002-8104-6419
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (TL1 DK132768, T32CA240172)
U.S. Department of Health & Human Services | National Institutes of Health
Patient-Centered Outcomes Research Training in Urologic and Gynecologic Cancers
- License Information
-
More Information
Article History
Received: 26 December 2022
Revised: 18 January 2023
Accepted: 23 January 2023
First Online: 2 February 2023
Competing interests
: SJF is a consultant to Bayer, Sanofi, Astellas, Astra Zeneca, Pfizer, Myovant, Janssen, and Merck. The other authors declare that they have no conflict of interest.
Free to read: This content has been made available to all.
